Clinical Trials
3 trialsNCT03259503 2025-11-10
Olaparib and High-Dose Chemotherapy in Treating Patients With Relapsed or Refractory Lymphomas Undergoing Stem Cell Transplant
M.D. Anderson Cancer Center
Phase 1 Completed
NCT03013933 2024-02-22
Brentuximab Vedotin, Cyclosporine, and Verapamil Hydrochloride in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
City of Hope Medical Center
Phase 1 Completed
NCT03291938 2020-11-24
IACS-010759 in Advanced Cancers
M.D. Anderson Cancer Center
Phase 1 Completed